PharmaTimes have reported that Allergan’s Botox is now licensed in the UK for patients who have continence issues because of multiple sclerosis or a spinal injury.
The Medicines and Healthcare products Regulatory Agency has give Allergan permission to use Botox (botulinum toxin type A) for managing urinary incontinence caused by neurogenic detrusor overactivity due to subcervical spinal cord injury or multiple sclerosis (MS),
Professor Christopher Chapple, Urology Department, Royal Hallamshire Hospital, Sheffield NHS Trust and a key investigator in the neurogenic detrusor overactivity registration trials, has welcomed the new license, noting that “being able to better control and manage bladder function can be life-changing for patients”.
If you are looking for a new job in science why not look at our current science based vacancies?
Click here to see our latest jobs in the science industry
Tags: Allergan, Biotech, Botox, chemicals, CK Science, Clinical jobs, engineering jobs, graduate science jobs uk, jobs in science, lab staff, medical devices, MS/spinal injury patients, pharma times, Pharmaceutical, recruitment agencies, Royal hallamshire Sheffield, science, science employment, science engineering jobs, science jobs, science jobs uk, science recruitment, scientific job agencies, scientific jobs, scientific recruiting, scientific recruitment agencies uk, scientific recruitment uk
